Obstetrics & Gynecology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Obstetrics & Gynecology 1989;74:921-926
© 1989 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KOONINGS, P. P.
Right arrow Articles by GRIMES, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KOONINGS, P. P.
Right arrow Articles by GRIMES, D. A.

Relative Frequency of Primary Ovarian Neoplasms: A 10-Year Review

PAUL P. KOONINGS, MD, KEITH CAMPBELL, MD, DANIEL R. MISHELL, Jr., MD and DAVID A. GRIMES, MD

From the Department of Obstetrics and Gynecology, University of Southern California School of Medicine, Women's Hospital, Los Angeles, California

Abstract

The relative frequency of ovarian neoplasms varies according to information in different texts. In an attempt to clarify the distribution of primary ovarian neoplasms by decades of life, a 10-year retrospective review of 861 women with a postoperative diagnosis of an ovarian neoplasm was undertaken. Benign cystic teratoma was the single most common ovarian neoplasm, accounting for 44% of all neoplasms, and was 57% more frequent than benign serous tumors. Germ cell neoplasms were the most common group of benign ovarian neoplasms; epithelial neoplasms were the most common malignant neoplasm. Stromal neoplasms and neoplasms of low malignant potential were uncommon at all ages. The risk that an ovarian neoplasm was malignant increased 12-fold from ages 20-29 to 60-69. The overall risk that an ovarian neoplasm was malignant was 13% in premenopausal women and 45% in postmenopausal women.




This article has been cited by other articles:


Home page
 J. Clin. Pathol.Home page
W G McCluggage
My approach to and thoughts on the typing of ovarian carcinomas
J. Clin. Pathol., February 1, 2008; 61(2): 152 - 163.
[Abstract] [Full Text] [PDF]

Home page
 Am Soc Clin Oncol Ed BookHome page
J. K. Wolf and J. Brown
Management of Stromal Tumors of the Ovary
ASCO Educational Book, January 1, 2008; 2008(1): 225 - 228.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
E. Gontier, M. Wartski, J.-M. Guinebretiere, and J.-L. Alberini
18F-FDG PET/CT in a patient with lymph node metastasis from ovarian adenocarcinoma.
Am. J. Roentgenol., September 1, 2006; 187(3): W285 - W289.
[Full Text] [PDF]

Home page
 RadiologyHome page
K. Kinkel, Y. Lu, A. Mehdizade, M.-F. Pelte, and H. Hricak
Indeterminate Ovarian Mass at US: Incremental Value of Second Imaging Test for Characterization--Meta-Analysis and Bayesian Analysis
Radiology, July 1, 2005; 236(1): 85 - 94.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. Brown, H. S. Shvartsman, M. T. Deavers, T. W. Burke, M. F. Munsell, and D. M. Gershenson
The Activity of Taxanes in the Treatment of Sex Cord-Stromal Ovarian Tumors
J. Clin. Oncol., September 1, 2004; 22(17): 3517 - 3523.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
S. E. Jung, J. M. Lee, S. E. Rha, J. Y. Byun, J. I. Jung, and S. T. Hahn
CT and MR Imaging of Ovarian Tumors with Emphasis on Differential Diagnosis
RadioGraphics, November 1, 2002; 22(6): 1305 - 1325.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
A. H. Dachman, A. Visweswaran, R. Battula, S. Jameel, and S. E. Waggoner
Role of Chest CT in the Follow-Up of Ovarian Adenocarcinoma
Am. J. Roentgenol., March 1, 2001; 176(3): 701 - 705.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
E. K. Outwater, E. S. Siegelman, and J. L. Hunt
Ovarian Teratomas: Tumor Types and Imaging Characteristics
RadioGraphics, March 1, 2001; 21(2): 475 - 490.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. Okubo, S. C. Mok, and S. Chen
Regulation of Aromatase Expression in Human Ovarian Surface Epithelial Cells
J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4889 - 4899.
[Abstract] [Full Text]

Home page
 RadiologyHome page
K. Kinkel, H. Hricak, Y. Lu, K. Tsuda, and R. A. Filly
US Characterization of Ovarian Masses: A Meta-Analysis
Radiology, December 1, 2000; 217(3): 803 - 811.
[Abstract] [Full Text]

Home page
 Obstet GynecolHome page
L. A. PADILLA, D. M. RADOSEVICH, and M. P. MILAD
Accuracy of the Pelvic Examination in Detecting Adnexal Masses
Obstet. Gynecol., October 1, 2000; 96(4): 593 - 598.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
Y.-Y. Jeong, E. K. Outwater, and H. K. Kang
Imaging Evaluation of Ovarian Masses
RadioGraphics, September 1, 2000; 20(5): 1445 - 1470.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
W G McCluggage
Recent advances in immunohistochemistry in the diagnosis of ovarian neoplasms
J. Clin. Pathol., May 1, 2000; 53(5): 327 - 334.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
C J R Stewart, C L Nandini, and J A Richmond
Value of A103 (melan-A) immunostaining in the differential diagnosis of ovarian sex cord stromal tumours
J. Clin. Pathol., March 1, 2000; 53(3): 206 - 211.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
S. Kawamoto, B. A. Urban, and E. K. Fishman
CT of Epithelial Ovarian Tumors
RadioGraphics, October 1, 1999; 19(90001): 85 - 102.
[Abstract] [Full Text]

Home page
 Endocr. Rev.Home page
H. Sasano and N. Harada
Intratumoral Aromatase in Human Breast, Endometrial, and Ovarian Malignancies
Endocr. Rev., October 1, 1998; 19(5): 593 - 607.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the American College of Obstetricians and Gynecologists.